Amgen Inc. (FRA:AMG)

Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of EUR 171.47 billion. The enterprise value is 210.78 billion.

Market Cap	171.47B
Enterprise Value	210.78B

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Feb 13, 2026

Share Statistics

Current Share Class	539.07M
Shares Outstanding	n/a
Shares Change (YoY)	+0.19%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	537.72M

Valuation Ratios

The trailing PE ratio is 26.11 and the forward PE ratio is 16.72.

PE Ratio	26.11
Forward PE	16.72
PS Ratio	5.48
PB Ratio	23.25
P/TBV Ratio	n/a
P/FCF Ratio	24.86
P/OCF Ratio	20.22
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.72, with an EV/FCF ratio of 30.55.

EV / Earnings	32.09
EV / Sales	6.76
EV / EBITDA	14.72
EV / EBIT	21.46
EV / FCF	30.55

Financial Position

The company has a current ratio of 1.14, with a Debt / Equity ratio of 6.40.

Current Ratio	1.14
Quick Ratio	0.73
Debt / Equity	6.40
Debt / EBITDA	3.29
Debt / FCF	6.84
Interest Coverage	3.66

Financial Efficiency

Return on equity (ROE) is 106.10% and return on invested capital (ROIC) is 18.12%.

Return on Equity (ROE)	106.10%
Return on Assets (ROA)	7.93%
Return on Invested Capital (ROIC)	18.12%
Return on Capital Employed (ROCE)	17.78%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	993,677
Profits Per Employee	208,491
Employee Count	31,500
Asset Turnover	0.40
Inventory Turnover	1.62

Taxes

In the past 12 months, Amgen has paid 1.08 billion in taxes.

Income Tax	1.08B
Effective Tax Rate	14.09%

Stock Price Statistics

The stock price has increased by +12.08% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+12.08%
50-Day Moving Average	289.90
200-Day Moving Average	263.72
Relative Strength Index (RSI)	65.76
Average Volume (20 Days)	203

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.59

Income Statement

In the last 12 months, Amgen had revenue of EUR 31.30 billion and earned 6.57 billion in profits. Earnings per share was 12.12.

Revenue	31.30B
Gross Profit	22.16B
Operating Income	9.86B
Pretax Income	7.64B
Net Income	6.57B
EBITDA	14.15B
EBIT	9.86B
Earnings Per Share (EPS)	12.12

Balance Sheet

The company has 7.78 billion in cash and 47.21 billion in debt, with a net cash position of -39.44 billion.

Cash & Cash Equivalents	7.78B
Total Debt	47.21B
Net Cash	-39.44B
Net Cash Per Share	n/a
Equity (Book Value)	7.37B
Book Value Per Share	13.69
Working Capital	3.04B

Cash Flow

In the last 12 months, operating cash flow was 8.48 billion and capital expenditures -1.58 billion, giving a free cash flow of 6.90 billion.

Operating Cash Flow	8.48B
Capital Expenditures	-1.58B
Free Cash Flow	6.90B
FCF Per Share	n/a

Margins

Gross margin is 70.78%, with operating and profit margins of 31.49% and 20.98%.

Gross Margin	70.78%
Operating Margin	31.49%
Pretax Margin	24.42%
Profit Margin	20.98%
EBITDA Margin	45.22%
EBIT Margin	31.49%
FCF Margin	22.04%

Dividends & Yields

This stock pays an annual dividend of 8.36, which amounts to a dividend yield of 2.64%.

Dividend Per Share	8.36
Dividend Yield	2.64%
Dividend Growth (YoY)	-1.96%
Years of Dividend Growth	15
Payout Ratio	66.45%
Buyback Yield	-0.19%
Shareholder Yield	2.46%
Earnings Yield	3.83%
FCF Yield	4.02%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Amgen has an Altman Z-Score of 1.65 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.65
Piotroski F-Score	7